|
|
|
Insider
Information: |
Barer Sol J |
Relationship: |
Director |
City: |
Warren |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
5,895,217 |
|
Indirect Shares
|
2,793,946 |
|
|
Direct
Value |
$81,858,749 |
|
|
Indirect Value
|
$6,974,534 |
|
|
Total
Shares |
8,689,163 |
|
|
Total
Value |
$88,833,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
Director |
2011-01-13 |
692,192 |
2011-01-13 |
61,281 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
Director |
2013-03-15 |
45,000 |
2009-11-04 |
0 |
Premium* |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2011-05-05 |
0 |
Premium* |
|
Inspiremd, Inc |
NSPR |
Director |
2016-03-21 |
1,141,690 |
2016-03-21 |
170,000 |
Premium* |
|
Aevi Genomic Medicine Inc |
GNMX |
Director |
2019-12-05 |
0 |
2019-12-05 |
0 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
Chairman of the Board,... |
2014-06-06 |
1,011,072 |
|
0 |
Premium* |
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
815,933 |
|
0 |
Premium* |
|
PDS Biotechnology Corp |
PDSB |
Director |
2015-10-06 |
0 |
2019-03-15 |
678,075 |
Premium* |
|
Teva Pharmaceutical Industries L... |
TEVA |
Director |
2023-08-04 |
371,516 |
2018-09-03 |
0 |
Premium* |
|
Neximmune, Inc. |
NEXI |
Director |
2022-11-17 |
1,817,814 |
2022-11-17 |
1,884,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
officerTitle |
|
2005-12-28 |
4 |
S |
$60.48 |
$15,119,300 |
I/I |
(250,000) |
0 |
|
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2016-11-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(29,890) |
0 |
0 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2019-12-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
519,700 |
0 |
0 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2019-12-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,551,020) |
0 |
0 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2019-12-05 |
4 |
S |
$0.13 |
$549,233 |
D/D |
(4,098,752) |
0 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2018-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,162 |
2,162 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2019-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,780 |
4,942 |
0 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
7,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Director |
|
2009-11-04 |
4 |
B |
$4.13 |
$82,600 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-09-19 |
4 |
B |
$5.57 |
$111,478 |
D/D |
20,000 |
27,000 |
2.39 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2011-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,890 |
29,890 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Director |
|
2013-03-15 |
4 |
B |
$3.40 |
$85,000 |
D/D |
25,000 |
45,000 |
2.39 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-09-20 |
4 |
B |
$6.50 |
$129,996 |
D/D |
20,000 |
47,000 |
2.39 |
- |
|
CELG |
Celgene Corp |
Chief Operating Officer |
|
2004-11-02 |
4 |
S |
$29.92 |
$5,054,657 |
D/D |
(168,956) |
62,660 |
|
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-11-11 |
4 |
B |
$6.80 |
$170,123 |
D/D |
25,000 |
72,000 |
2.39 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-12-02 |
4 |
B |
$6.59 |
$131,780 |
D/D |
20,000 |
92,000 |
2.39 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-12-13 |
4 |
B |
$5.37 |
$107,422 |
D/D |
20,000 |
112,000 |
2.39 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2019-06-03 |
4 |
B |
$8.98 |
$997,013 |
D/D |
111,000 |
115,942 |
2.39 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
119,000 |
0 |
- |
|
NEXI |
Neximmune, Inc. |
Director |
|
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
129,007 |
|
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2015-10-06 |
4 |
B |
$6.50 |
$999,999 |
I/I |
153,846 |
153,846 |
2.1 |
- |
|
CELG |
Celgene Corp |
Chief Operating Officer |
|
2005-03-02 |
4 |
OE |
$8.82 |
$1,082,491 |
D/D |
115,404 |
178,064 |
|
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2014-05-12 |
4 |
B |
$6.91 |
$414,300 |
D/D |
60,000 |
179,000 |
2.39 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2013-07-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
850,000 |
200,000 |
0 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2014-05-12 |
4 |
B |
$2.42 |
$11,602 |
D/D |
4,800 |
204,800 |
2.39 |
- |
|
122 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|